In conclusion, BCL-3 may represent an exciting new route for targeting the Hallmarks of Cancer; in particular by limiting the impact of the enabling hallmarks of tumour promoting inflammation and cell plasticity. The gene discussed is BCL3; the disease is neoplasm.